Leerink Partnrs Lowers Earnings Estimates for Exact Sciences
Exact Sciences Co. (NASDAQ:EXAS – Free Report) – Investment analysts at Leerink Partnrs decreased their Q1 2025 earnings estimates for Exact Sciences in a report issued on Monday, April 21st. Leerink Partnrs analyst P. Souda now expects that the medical research company will earn ($0.14) per share for the quarter, down from their prior estimate […]
Exact Sciences Co. (NASDAQ:EXAS – Free Report) – Investment analysts at Leerink Partnrs decreased their Q1 2025 earnings estimates for Exact Sciences in a report issued on Monday, April 21st. Leerink Partnrs analyst P. Souda now expects that the medical research company will earn ($0.14) per share for the quarter, down from their prior estimate […]
